chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hot; itches like crazy; one week after receiving the vaccine at the site of injection she has a huge arm rash; bright red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red). At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Approx 8 hours after the Covid vaccine I began having tingling and nerve zaps in all limbs. These pains have continued since for the past 10 days and have not stopped.
Pt. got dizzy and very red in face after a minute of getting vaccine. She said she had trouble breathing. After a few minutes, pt passed out, lips turned blue, and when she came to a minute later she vomited and EMS arrived. She was responsive from then on. (All happened in course of 10 minutes).
Patient vaccinated x2 (Moderna): 9/24/22, 9/24/22  Patient COVID+ on 4/15/22 while hospitalized
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information about the patient's medical history and concurrent conditions was not reported. On 13-AUG-2015, the patient was vaccinated with improperly stored dose of (Oka/Merck) VARIVAX, lot # L007227, expiration date: 03-MAR-2016  (administration route was not reported). No concomitant therapies were reported. No adverse effects were reported. According to the reporting nurse the dose were exposed to a temperature excursion from 12-AUG-2015 to 13-AUG-2015 for a total of 17 hours at 5.5C. This is one of several reports from the same reporter. Additional information has been requested.
MCV4 administered on 8/3/06 at 11:45am.  At 4pm on 8/3/06, pain in neck and down to mid-spine, mild at first.  Then at 4am on 8/4/06, increased pain, weakness, ankles, and arms with abdominal pain.  Described as "felt drained"  MD visit -  ordered Tylenol; little relief for next 12-24 hours.
Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No medical history. ).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
She got her vaccine, had no reaction.  Thursday morning her arm was still fine.  About 8:00 PM she was laying in bed watching TV, her nose started to run, her throat was hurting and her eyes were burning.  She was having trouble breathing, took her inhaler, her legs felt like jello, lymph node under her right arm was painful and was not able to get out of bed.  She called the HCF and they told her that it takes 48 hours for the antibodies to start and to call her PCP.  She called him and was started on Augmentin on Friday.  Thursday night she started to take Mucinex, then the antibiotics and felt like she was going to die.  She is starting to feel better today.  She felt so bad that she was going to call 9-1-1.  Her doctor told her that he felt that it was the lymph node under the arm too.  She is scheduled for blood work on Thursday and is going to look at it then.    With her J&J vaccines she had some soreness in her arm, but nothing severe and was gone in a day.
Info has been received from a physician concerning a male pt who was vaccinated SC in the left arm with a dose of pneumococcal vaccine 23 polyvalent. The reporter indicated that 8 hours after receiving the injection, the pt developed paresthesia of the arm and is experiencing motor weakness of his left hand. No medical attention was sought. Additional info has been requested.
Information has been received from a physician concerning a baby's mother who had rotavirus after her baby was vaccinated with a dose of ROTATEQ. The baby's grandmother (WAES# 0805USA00049) also experienced rotavirus. The physician was contacted by phone for medical attention. The outcome was unknown. No additional information at this time. There was no product quality complaint. Additional information has been requested. Follow-up information from the administering health professional in the reporting physician's office indicated that on 14-Apr-2008 the baby was vaccinated and in April 2008, the baby's mother experienced rotavirus.
This is a spontaneous report from a contactable medical assistant calling on behalf of the physician. This is a spontaneous report from a contactable other hcp. An 80-year-old male patient received PREVNAR 13 lot R19477 exp date 31Jan2018, via an unspecified route of administration in right deltoid on 08Feb2017 10:30 at 0.5 ml, single for immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced severe fatigue two days after vaccination in Feb2017 with outcome of unknown. He had a complete work up and everything came back normal and the physician feels that it must relate to the vaccination.
The patient reported to get the Moderna booster 3 day ago, in subconscious tissue and not the deltoid muscle/does not think the shot was given to her intramuscularly instead the shot was given subcutaneously; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The patient reported to get the Moderna booster 3 day ago, in subconscious tissue and not the deltoid muscle/does not think the shot was given to her intramuscularly instead the shot was given subcutaneously) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. In October 2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The patient reported to get the Moderna booster 3 day ago, in subconscious tissue and not the deltoid muscle/does not think the shot was given to her intramuscularly instead the shot was given subcutaneously). In October 2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The patient reported to get the Moderna booster 3 day ago, in subconscious tissue and not the deltoid muscle/does not think the shot was given to her intramuscularly instead the shot was given subcutaneously) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   The patient was a nurse and experienced no adverse effects. The patient would like another booster shot.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Reporter contact information was added and vaccination details was updated.
Localized swelling, redness, and tenderness observed by this ARNP and presence of itching reported by patient on 09/22/2016. Red maculopapular rash described by patient in preceding days.
Site: Pain at Injection Site-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe
Person tested positive after receiving vaccination; Person tested positive after receiving vaccination; This is a spontaneous report from a non-contactable consumer. The consumer reported for a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The consumer stated that the "person tested positive after receiving vaccination" on an unspecified date. The patient lab test and procedures which included sars-cov-2 test was positive after receiving vaccination. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Client c/o slight feeling of lethargic.  When asked, client voiced that he had eaten and feels really tired immediately after receiving vaccine.  Client seen and assessed by EMT and VS are: BP 140/90, HR 87, O2 95%.  Client advise to seek pcp if symptoms worsen.  Client verbalized understanding and cleared to go home with spouse by EMT.
On day 3 woke up with rash over upper part of the body.  Called PCP office, saw PA in office and was put on Prendisone.
Post herpetic neuralgia; This non-serious case was reported by a consumer via call center representative and described the occurrence of post herpetic neuralgia in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (diagnosed with shingles approximately two years ago).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced post herpetic neuralgia (Verbatim: Post herpetic neuralgia). The outcome of the post herpetic neuralgia was not resolved.   It was unknown if the reporter considered the post herpetic neuralgia to be related to Shingrix.     It was unknown if the company considered the post herpetic neuralgia to be related to Shingrix.   Additional Information: GSK Receipt date: 09-NOV-2023 Consumer was the reporter. The patient received first dose of Shingrix about 2 months ago and now experiencing postherpetic neuralgia. The consumer reported that postherpetic neuralgia felt the same as when he had an active case of shingles. No further information was known. The reporter did not consent to follow-up.
Developed 2 hive like welts on chest that I thought might be bug bites because they were very painful itchy and swollen with fluid in them.   After a few days more of them developed until there were about 22 on my legs, arms and chest.   Very painful and inflamed and itchy.   They are as painful as shingles but there are none on the midline or abdomen.    I saw physician and he determined it was a reaction to the vaccine.  I have never had a reaction to a vaccine before nor have I ever had welts as painful or like these.  He prescribed prednisone which I am taking now.   I have only finished one day of oral prednisone and the swelling on the site have started to improve but I still have pain itching and have 3 new ones that have come up.   One on the lateral breast and the other two on the anterior breast (superior).
This spontaneous report was received on 27-APR-2017 from a nurse referring to unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug and allergy history were not reported. On unspecified dates, the patients were vaccinated with improperly stored injections of GARDASIL 9 lot number M037770, expiration date 01-JUN-2019 (strength, dose, route of administration were not reported) for prophylaxis.  The patients' concomitant therapies were not reported. The vaccines were exposed to the following temperature of 32° Fahrenheit (F) to 35°F (lowest temperature was 35°F) for a time frame of 72 hours.  The call was not due to a data logger.  There were no previous temperature excursions. Adverse effects were not reported. This is one of three reports received from the same source. Additional information is not expected as the reporter did not consent for follow-up attempts.; Sender's Comments:  US-009507513-1704USA014987: US-009507513-1706USA000258:
Within 15 min. experienced tightening in throat but wasn't alarmed, about 45 min after injection became hot, itching, nauseated and felt throat "swelling", around 3:10 felt tongue swelling and became dizzy and couldn't breath well,  employee transferred to Hospital via EMS.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old male patient who received SHINGRIX for prophylaxis. On 1st May 2018, the patient received the 1st dose of SHINGRIX. On 1st May 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details reported as follows: The reporter was the patient's wife. The patient received 1st dose and experienced a sore arm. For tolerance after 2nd dose refer case US2018GSK151123. This case has been linked with US2018147867 and US2018GSK150555, reported by same reporter.
Patient was administered 0.5 ml Jannsen COVID-19 vaccine  into the left deltoid with no complaints. After completion of vaccine patient continue to sit in waiting area, while sitting in waiting area patient described feeling extremely dizzy and hot. Patient was given water/Benadryl and was able to alleviate issue without any further action necessary.
This case was reported in a literature article and described the occurrence of pneumonia in a infant subject who received Rotavirus vaccine for prophylaxis. Concurrent medical conditions included combined immunodeficiency syndrome (severe combined immunodeficiency disease). On an unknown date, unknown after receiving Rotavirus vaccine, the subject developed pneumonia. Serious criteria included death and GSK medically significant. The outcome of pneumonia was fatal. The reported cause of death was pneumonia. The investigator considered that there was a reasonable possibility that the pneumonia may have been caused by Rotavirus vaccine. Additional information was provided. This case was reported in a literature article and described the occurrence of pneumonia in an infant of unspecified age and gender who was vaccinated with unspecified rotavirus vaccine (manufacturer unknown) for prophylaxis. This case corresponds to table 1 reported in this literature article. The patient was part of the study that characterize adverse events (AE) after rotavirus (RV) in infants with immunocompromising conditions (IC) reported to the Vaccine Adverse Event Reporting System (VAERS) from February 2006 to December 2015. The patient had severe combined immunodeficiency disease (SCID). No information on patient's medical or family history or concomitant medication were provided. On an unspecified date, the patient received unspecified rotavirus virus vaccine (administration route and site unspecified, dosage unknown; batch number not provided). The age of vaccination was not provided. On an unspecified date, an unknown period after vaccination, the patient developed pneumonia. On an unspecified date, the patient died. The cause of death was pneumonia. It was unknown if an autopsy was performed. This case has been considered as serious due to death. The treatment was unknown. The author stated and concluded, "Adverse event (AE) after RV in immunocompromised infants are rarely reported to VAERS, but most are clinically serious events. Additional data would be helpful in assessing the safety of RV in non-SCID IC including in-utero exposure to monoclonal antibodies MAB". This is 1 of the 11 valid cases reported in this literature article. The article corresponding to this case is not available for submission due to copyright restriction. Reported Cause(s) of Death: Pneumonia.
Raised pale 1 cm wheal come up within a few seconds after VARICELLA SQ shot in L arm. Administered 1 tsp of BENADRYL Orally and applied cool pack to arm.
This spontaneous case reported by a pharmacist, describes the occurrence of administered expired product (patients vaccinated with expired doses) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 026L21B) for COVID-19 immunization. No medical history reported. On Apr 4, 2022, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; .25 milliliter. On Apr 4, 2022, patient administered expired product (patients vaccinated with expired doses). At the time of the report, administered expired product (patients vaccinated with expired doses) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. It was reported the pharmacist thought the expiry date of the vaccine was June 2022, however the vaccine expired on Apr 1, 2022. The vial didn't undergo temperature excursion issue. Vaccine placed in refrigerator on Apr 4, 2022.
Upset stomach after 1st dose; Achy body after 1st dose; Chills after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset stomach after 1st dose), PAIN (Achy body after 1st dose) and CHILLS (Chills after 1st dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 17B218 and 032B218) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Type 1 diabetes mellitus. Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN ASPART (NOVOLOG), GABAPENTIN, LISINOPRIL and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach after 1st dose), PAIN (Achy body after 1st dose) and CHILLS (Chills after 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach after 1st dose), PAIN (Achy body after 1st dose) and CHILLS (Chills after 1st dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-098835.
onset of left sided mouth numbness & weakness associated with change    in taste but no change in sense of smell over the past 2 days- woke    up 2 days ago with subtle changes to the left mouth - no associated    other symptoms of headache, sore throat ear pain or drainage & no    skin lesions to the nose, ear or left cheek; no stiff neck , sore    throat, fever, chills, rigors * no recenbt URI symptoms or trauma to    the left ear ie using Qtips; denies prior similar symptoms & no    associated visual changes , double vision or partial visual field    changes ie amuarosis fugax, teichopsia or pallisading;
Got really dizzy; we gave him some cold water and had him lay down for 10 min and he felt better.
At first the area surrounding the vaccination site was very puffy, itchy, and red.  A few days later the surface of the skin in the area was covered with small blisters, similar in appearance to sunburn blisters.  The blisters are now gone, but the skin is very irritated, and the inflamed area has increased in size significantly (about the size of a silver dollar right now).  Additionally, there is some discoloration that looks similar to bruising, but I can't think of a reason I would have a bruise there.  It doesn't itch anymore, but it is still very painful when touched.  Will continue to monitor and seek medical attention if it doesn't seem to be getting better.
Got up on Friday morning and almost fell over and had to be careful not to fall while walking to bathroom to get a shower.  That night I was dizzy and could not lay down and especially could not lay on side so I propped up pillows and slept upright.  Same thing Saturday night but less.  Some thing on Sunday night but much less.  Just a little spaced out on Monday and slight headache.  CAlled doctor, no call back yet but I did not want to go to ER.  So far it is going in the right direction.  Had minor headache initially, night 2, but tylenol worked to relieve.
Breakthrough case. I didn't feel good, I was really tired and congested. Took a Home COVID-19 test and it was positive. I had a telehealth appointment with my Dr and he prescribed Paxlovid. I finished the prescription and started to feel better slowly. I retook the Home COVID-19 test on 08/01/2022 and it was negative.
itchiness of hands and wrist; rash on extremities; hot flashes; raised temp; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (raised temp), HEADACHE (headache), HOT FLUSH (hot flashes), PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (raised temp) and HEADACHE (headache). On 05-Feb-2021, the patient experienced HOT FLUSH (hot flashes). On 07-Feb-2021, the patient experienced PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities). At the time of the report, PYREXIA (raised temp), HEADACHE (headache), HOT FLUSH (hot flashes), PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
Pt reports that 3-4 days after injection her arm started swelling, became warm, red, and itchy. The area of swelling was baseball size. Pt used no interventions and the symptoms were gone after 2 days.
Awoke pale, beat red blotches on face and neck. Temperature was 102F with a headache, light-headed and nauseated. Denies wheezing or shortness of breath.
On 11/5/23 the patient reported having several days of severe chills and presented with 3 red round bumps on his arm in the area of the vaccination. They were approximately 1/4-inch and looked like bug bites. He said they had appeared 2 to 3 days prior and that they were sore to the touch. He said it seemed like maybe they were getting better, not worse. He was not concerned about needing treatment, he just wanted to report the reaction.